EffRx Mourns Passing of Board Member Anders Wiklund

August 19, 2020

EffRx Mourns Passing of Board Member Anders Wiklund

FREIENBACH, Switzerland, 19th August 2020.

The leadership of EffRx Pharmaceuticals SA is extremely saddened to announce the passing of longtime Board Member and former Chairman, Anders P. Wiklund.

Anders, a Swedish citizen, has been a board member of EffRx since its incorporation in Switzerland in 2009, and served as Chairman of EffRx between 2015 and 2016. He also acted as CEO at former EffRx Inc., USA.

“Anders will be greatly missed by the entire EffRx family. We are deeply saddened by his passing and by the loss of a friend and colleague. We are especially honored for the entrepreneurial passion towards healthcare he carried in his heart and thankful for his outstanding leadership, experience and wisdom”, said Lorenzo Bosisio, CEO of EffRx. “Anders will always remain an indelible role model in our thoughts.”

On behalf of our Board of Directors, management team and employees, we extend our deepest sympathies to Anders’ family.

About EffRx Pharmaceuticals SA

EffRx Pharmaceuticals is a commercial-stage pharmaceutical company focused on the late-stage development and commercialization of prescription medications for niche and orphan indications. The business model is centered around providing superior clinical and commercial value propositions for physicians, payers and patients.